Trump administration to modernize flu vaccines via government buying power

The U.S. government is laying plans to harness its buying power and applied research capabilities to pull influenza vaccine development and manufacturing into the 21st century. The goals are to enhance protection against seasonal flu, and in the process create infrastructure that could provide rapid, effective responses to pandemic strains.

An Executive Order (EO) on modernizing influenza vaccines signed by President Donald Trump on September 19, and a Council of Economic Advisers (CEA) report released with it, outline the public health, national security and economic imperatives to change the way flu vaccines are manufactured. ...